CXCR4 and neuropathy: Although there is support for spinal cord-infiltrating CD4+ T lymphocytes in contributing to neuropathic pain due to spinal nerve transection injury[67], chemotherapy-induced neuropathy does not appear to be influenced by either this cell type or the CXCR4 antagonist AMD3100.